GTS Securities’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
– Sell
-124,300
Closed -$12.9M – 1771
2024
Q3
$12.9M Buy
124,300
+10,500
+9% +$1.07M 0.03% 404
2024
Q2
$11M Sell
113,800
-15,900
-12% -$1.47M 0.02% 459
2024
Q1
$11.7M Buy
129,700
+300
+0.2% +$25.4K 0.02% 443
2023
Q4
$10.3M Buy
129,400
+62,200
+93% +$4.68M 0.02% 591
2023
Q3
$4.78M Buy
+67,200
New +$5.02M 0.01% 954

Other funds holding CL

GTS Securities's CL Position: Q3 2026 in Review

GTS Securities increased its Colgate-Palmolive (CL) stake by 109% in Q3 2026, buying an estimated $246K and bringing the position to 5,232 shares worth $446K. The position accounts for 0.01% of the portfolio, ranked #987.

GTS Securities first reported a position in CL in Q2 2023 and has held it in 12 quarters since. The position peaked at $1.98M in Q4 2024. 1,966 funds tracked by Wall St. Rank hold CL as of Q3 2026.

  • GTS Securities held 5,232 shares of Colgate-Palmolive worth $446K as of Q3 2026.
  • GTS Securities bought 2,723 Colgate-Palmolive shares in Q3 2026, an estimated $246K.
  • Colgate-Palmolive made up 0.01% of GTS Securities's portfolio in Q3 2026, its #987 holding.
  • GTS Securities first reported a position in Colgate-Palmolive in Q2 2023 and has held it in 12 quarters since.
  • GTS Securities's Colgate-Palmolive position peaked at $1.98M in Q4 2024.
  • 1,966 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q3 2026.

Based on GTS Securities's 13F filing for Q3 2026, filed 16 Nov 2026.